Joensuu H - Search Results

1

Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib.

Lee CK, Goldstein D, Gibbs E, Joensuu H, Zalcberg J, Verweij J, Casali PG, Maki RG, Cioffi A, Mcarthur G, Lord SJ, Yip D, Kanjanapan Y, Rutkowski P. Lee CK, et al. Among authors: joensuu h. Eur J Cancer. 2015 May;51(7):852-60. doi: 10.1016/j.ejca.2015.02.015. Epub 2015 Mar 19. Eur J Cancer. 2015. PMID: 25801699 Clinical Trial.

2

Treatment of metastatic carcinoid tumour with recombinant interferon alfa.

Joensuu H, Kumpulainen E, Gröhn P. Joensuu H, et al. Eur J Cancer. 1992;28A(10):1650-3. doi: 10.1016/0959-8049(92)90061-6. Eur J Cancer. 1992. PMID: 1382493

3

Effect of DNA ploidy classification on prognosis in breast cancer.

Joensuu H, Alanen K, Falkmer UG, Klemi P, Nordling S, Remvikos Y, Toikkanen S. Joensuu H, et al. Int J Cancer. 1992 Nov 11;52(5):701-6. doi: 10.1002/ijc.2910520506. Int J Cancer. 1992. PMID: 1428229

4

Prognosis of lymphoma from a fine-needle aspirate.

Joensuu H, Alanen K, Klemi PJ. Joensuu H, et al. Eur J Cancer. 1992;29A(1):29-33. doi: 10.1016/0959-8049(93)90571-v. Eur J Cancer. 1992. PMID: 1445742

5

Factors predicting late mortality from breast cancer.

Toikkanen SP, Kujari HP, Joensuu H. Toikkanen SP, et al. Among authors: joensuu h. Eur J Cancer. 1991;27(5):586-91. doi: 10.1016/0277-5379(91)90224-2. Eur J Cancer. 1991. PMID: 1828967

6

Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma.

Joensuu H, Ristamäki R, Klemi PJ, Jalkanen S. Joensuu H, et al. Br J Cancer. 1993 Aug;68(2):428-32. doi: 10.1038/bjc.1993.354. Br J Cancer. 1993. PMID: 8347502 Free PMC article.

7

Late mortality from pT1N0M0 breast carcinoma.

Joensuu H, Pylkkänen L, Toikkanen S. Joensuu H, et al. Cancer. 1999 May 15;85(10):2183-9. doi: 10.1002/(sici)1097-0142(19990515)85:10<2183::aid-cncr12>3.0.co;2-k. Cancer. 1999. PMID: 10326696

8

Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF.

Poikonen P, Saarto T, Lundin J, Joensuu H, Blomqvist C. Poikonen P, et al. Among authors: joensuu h. Br J Cancer. 1999 Aug;80(11):1763-6. doi: 10.1038/sj.bjc.6690594. Br J Cancer. 1999. PMID: 10468293 Free PMC article. Clinical Trial.

9

Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients.

Poikonen P, Saarto T, Elomaa I, Joensuu H, Blomqvist C. Poikonen P, et al. Among authors: joensuu h. Eur J Cancer. 2000 Jan;36(1):43-8. doi: 10.1016/s0959-8049(99)00225-7. Eur J Cancer. 2000. PMID: 10741293

10

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.

Joensuu H, Roberts PJ, Sarlomo-Rikala M, Andersson LC, Tervahartiala P, Tuveson D, Silberman S, Capdeville R, Dimitrijevic S, Druker B, Demetri GD. Joensuu H, et al. N Engl J Med. 2001 Apr 5;344(14):1052-6. doi: 10.1056/NEJM200104053441404. N Engl J Med. 2001. PMID: 11287975 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

615 results

Search Page

Filters